Phio Pharmaceuticals Corp (PHIO ፦ ) የአክሲዮን ዋጋ እና ዜና

መነሻPHIO • NASDAQ

Phio Pharmaceuticals Corp

$2.96

ከሰዓታት በኋላ፦

$2.99

(1.01%)+0.030

ዝግ፦ ጁን 6, 8:00:00 ከሰዓት ጂ ኤም ቲ-4 · USD · NASDAQ · ተጠያቂነትን ማንሳት

ክምችትበዩናይትድ ስቴትስ የተዘረዘረ ደህንነትዋና መስሪያ ቤቱ ዩናይትድ ስቴትስ ውስጥ የሆነ

የቀዳሚ መዝጊያ

$2.46

የቀን ክልል

$2.53 - $3.19

የዓመት ክልል

$0.97 - $9.79

የገበያው አጠቃላይ ዋጋ

14.20 ሚ USD

አማካይ መጠን

895.03 ሺ

የዋጋ/ገቢ ምጥጥን

የትርፍ ክፍያ

ዋና ልውውጥ

NASDAQ

ዜና ላይ

Yahoo Finance

ከ1 ቀን በፊት

Phio Pharmaceuticals Announces Strategic Initiative to Create Awareness of the Comprehensive INTASYL siRNA Portfolio

Investing.com

ከ2 ቀናት በፊት

H.C. Wainwright assumes coverage on Phio Pharma stock with Buy rating

ስለ

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia

የተመሰረተው

2011

ዋና መሥሪያ ቤት

Marlborough፣ ማሣቹሰትስ
ዩናይትድ ስቴትስ

ድህረገፅ

phiopharma.com

ሠራተኞች